PDS Biotechnology Updates Phase 3 Trial to Accelerate PDS0101 Approval PathBy Corporate Leaders MagazineFebruary 21, 2026 Key Highlights PDS Biotech amended its Phase 3 VERSATILE-003 trial to include progression-free survival (PFS) as an interim primary endpoint.…
Jade Biosciences Secures $45M in Private Placement Led by BB BiotechBy Corporate Leaders MagazineDecember 16, 2025 Key Highlights Jade Biosciences raises approximately $45 million through a private placement with BB Biotech as shares surge over 120%…
Why We’re Launching GEN BiotechnologyBy Corporate Leaders MagazineOctober 18, 2021 In 1981, Genetic Engineering and Biotechnology News launched as the newspaper of record for the fledgling biotechnology industry. Publications come and go,…
